Arotech Corporation (Nasdaq:ARTX) today announced
financial results for its third quarter and nine months ended
September 30, 2016.
Third Quarter 2016 Financial and Business
Highlights:
- Total revenues of $24.3 million
- Net income of $636,000; income from continuing operations of
$1.5 million
- Diluted net income per share of $0.02; continuing
operations diluted income per share of $0.06
- Adjusted EPS of $0.10 (reconciliation to diluted EPS appears in
tables below)
- Adjusted EBITDA of $3.1 million (reconciliation to net income
appears in tables below)
- Backlog of orders as of September 30, 2016 totaled $55 million
versus $61.1 million as of the same period last year and $52
million as of June 30, 2016
U.S. $ in
thousands, except per share data |
|
Third Quarter |
|
|
Second Quarter |
|
|
2016 |
|
2015 |
|
|
|
2016 |
|
GAAP
Measures |
|
|
|
|
|
|
|
|
|
Revenue |
|
$ |
24,300 |
|
$ |
|
23,289 |
|
|
$ |
|
21,780 |
|
Net income/(loss) |
|
$ |
636 |
|
$ |
|
(618 |
) |
|
$ |
|
(800 |
) |
Diluted net income/loss
per share |
|
$ |
0.02 |
|
$ |
|
(0.03 |
) |
|
$ |
|
(0.03 |
) |
|
|
|
|
|
|
|
|
|
|
Non-GAAP
Measures |
|
|
|
|
|
|
|
|
|
Adjusted EBITDA from
continuing operations |
|
$ |
3,121 |
|
$ |
|
1,796 |
|
|
$ |
|
1,069 |
|
Adjusted EPS from
continuing operations |
|
$ |
0.10 |
|
$ |
|
0.04 |
|
|
$ |
|
0.01 |
|
“Arotech had strong gross margins in the third
quarter which led to solid results,” commented Steven Esses,
Arotech’s President and CEO. “Our focus on cost control is showing
results, while we continue to position ourselves for important
contracts that will bring back top line growth. We are encouraged
with the third quarter results as they reflect strong execution on
many levels. Our design, development and
production efforts are leading to contract completions at or ahead
of budgets in many cases.”
“Our results through three quarters, together
with our forecast for the remainder of the year, lead us to confirm
our previously given adjusted EBITDA and EPS guidance ($7-$8
million and $0.18-$0.20 per share), but we now expect to fall
slightly below our revenue guidance of $100M for the year. The bulk
of our business remains defense related, and we are finding it
challenging to predict the timing of new awards.”
Third Quarter Financial
Summary
Revenues for the third quarter were $24.3
million, compared to $23.3 million for the comparable period in
2015.
Gross profit for the third quarter was $7.9
million, or 32.4% of revenues, compared to $7.0 million, or 30.2%
of revenues, for the prior year period.
Operating income for the third quarter of 2016
was $1.8 million, compared to Operating Income of $357,000 for the
corresponding period in 2015. Included in operating income were
operating expenses of $6.0 million in the third quarter of 2016
compared to $6.7 million in the year ago quarter.
Total other expenses were $(224,000) for the
third quarter of 2016 and $(422,000) for the corresponding period
in 2015.
The Company’s net income from continuing
operations for the third quarter was $1.5 million, or $0.06 per
basic and diluted share, compared to a net loss of $(355,000), or
$(0.02) per basic and diluted share, for the corresponding period
last year.
The Company’s net income (including discontinued
operations) for the third quarter was $636,000 or $0.02 per basic
and diluted share versus a loss of $(618,000) or $(0.03) per basic
and diluted share in the third quarter of 2015.
Adjusted Earnings per Share (Adjusted EPS) was
$0.10 for the third quarter of 2016 and $0.04 for the corresponding
period in 2015.
Adjusted Earnings Before Interest, Taxes,
Depreciation and Amortization (Adjusted EBITDA) was approximately
$3.1 million for the third quarter of 2016 and $1.8 million for the
corresponding period of 2015.
Arotech believes that information concerning
Adjusted EPS and Adjusted EBITDA enhances overall understanding of
its current financial performance. Arotech computes Adjusted EPS
and Adjusted EBITDA, which are non-GAAP financial measures, as
reflected in the tables below.
Year-to-Date Financial
Summary
Revenues for the first nine months of 2016 were
$71.5 million, compared to $69.2 million for the comparable period
in 2015. The year-over-year increase was driven, in large part, by
revenue growth in the Company’s Power Systems Division.
Gross profit for the first nine months of 2016
was $22.6 million, or 31.5% of revenues, compared to $20.2 million,
or 29.1% of revenues, for the prior year period.
Operating income for the first nine months of
2016 was $2.0 million versus an operating loss of $(910,000) for
the corresponding period in 2015. Included in operating income was
$20.6 million of operating expenses in 2016 compared to $21.7
million in the corresponding period in 2015
Total other expense for the first nine months of
2016 were $(719,000) compared to total other expense of $(943,000)
for the corresponding period in 2015. The difference was driven by
lower interest expense incurred as a result of less total debt
outstanding and lower interest rates in 2016 as compared to
2015.
The Company’s net income from continuing
operations for the first nine months of 2016 was $554,000, or $0.02
per basic and diluted income per share, compared to a net loss of
$(2.8) million, or $(0.12) per basic and diluted share, for the
corresponding period last year.
The Company’s net loss for the first nine months
of 2016 was $(808,000), or $(0.03) per basic and diluted share,
compared to a loss of $(3.3) million, or $(0.14) per basic and
diluted share, for the corresponding period last year.
Adjusted Earnings per Share (Adjusted EPS) for
the first nine months of 2016 was $0.16, compared to $0.04 for the
corresponding period in 2015.
Adjusted Earnings Before Interest, Taxes,
Depreciation and Amortization (Adjusted EBITDA) for the first nine
months of 2016 was $6.2 million compared to $3.5 million for the
corresponding period of 2015.
Arotech believes that information concerning
Adjusted EPS and Adjusted EBITDA enhances overall understanding of
its current financial performance. Arotech computes Adjusted EPS
and Adjusted EBITDA, which are non-GAAP financial measures, as
reflected in the tables below.
Balance Sheet Metrics
As of September 30, 2016, the Company had $10.6
million in cash and cash equivalents, as compared to $10.7 million
in cash and cash equivalents at December 31, 2015.
As of December 31, 2015, Arotech has net
operating loss carryforwards for U.S. federal income tax purposes
of $40.7 million, which are available to offset future taxable
income, if any, expiring in 2021 through 2032. Utilization of U.S.
net operating losses is subject to annual limitations due to
provisions of the Internal Revenue Code of 1986 and similar state
provisions. The Company accrued $229,000 in non-cash tax expenses
in the third quarter of 2016, reflecting the uncertainty of the
deductibility of intangible expenses for federal income tax
purposes.
As of September 30, 2016, the Company had total
debt of $18.2 million, consisting of $7.4 million in short-term
bank debt under its credit facility and $10.8 million in long-term
loans. This is in comparison to December 31, 2015 when the Company
had total debt of $20.3 million, consisting of $4.1 million in
short-term bank debt and $16.2 million in long-term loans.
The Company also had $7.6 million in available,
unused bank lines of credit with its primary bank as of September
30, 2016, under a $15.0 million credit facility through its main
bank.
The Company had a current ratio (current
assets/current liabilities) of 2.1 compared with the December 31,
2015 current ratio of 1.9.
Conference Call
The Company will host a conference call
tomorrow, Wednesday, November 9, 2016 at 9:00 a.m. Eastern time, to
review the Company’s financial results and business outlook.
To participate, please call one of the following
telephone numbers. Please dial in at least 10 minutes before the
start of the call:
- US: 1-800-862-7084
- International: + 785-424-1181
- Conference ID: AROTECH
The conference call will also be broadcast live
as a listen-only webcast on the investor relations section of
Arotech’s website at http://www.arotech.com/.
A telephonic playback of the conference call
will be archived on Arotech’s website for at least 90 days and a
telephonic playback of the conference call will also be available
by calling 1-877-481-4010 within the U.S. and 1-919-882-2331
internationally. The telephonic playback will be available
beginning at 12:00 pm Eastern time on Wednesday, November 9, 2016,
and continue through 11:59 pm Eastern time on November 15, 2016.
The replay passcode is 10510.
About Arotech Corporation
Arotech Corporation is a leading provider of
quality defense and security products for the military, law
enforcement and homeland security markets, including multimedia
interactive simulators/trainers and advanced battery solutions,
innovative energy management and power distribution technologies,
and zinc-air and lithium batteries and chargers. Arotech operates
two major business divisions: Training and Simulation, and Power
Systems.
Arotech is incorporated in Delaware, with
corporate offices in Ann Arbor, Michigan, and research, development
and production subsidiaries in Michigan, South Carolina, and
Israel. For more information on Arotech, please visit Arotech’s
website at www.arotech.com.
Investor Relations Contact:
Andrea
Herman+1-516-874-0597andrea.h@arotech.com
Except for the historical information herein,
the matters discussed in this news release include forward-looking
statements, as defined in the Private Securities Litigation Reform
Act of 1995. Forward-looking statements reflect management’s
current knowledge, assumptions, judgment and expectations regarding
future performance or events. Although management believes that the
expectations reflected in such statements are reasonable, readers
are cautioned not to place undue reliance on these forward-looking
statements, as they are subject to various risks and uncertainties
that may cause actual results to vary materially. These risks and
uncertainties include, but are not limited to, risks relating to:
product and technology development; the uncertainty of the market
for Arotech’s products; changing economic conditions; delay,
cancellation or non-renewal, in whole or in part, of contracts or
of purchase orders (including as a result of budgetary cuts
resulting from automatic sequestration under the Budget Control Act
of 2011); and other risk factors detailed in Arotech’s most recent
Annual Report on Form 10-K for the fiscal year ended December 31,
2015, and other filings with the Securities and Exchange
Commission. Arotech assumes no obligation to update the information
in this release. Reference to the Company’s website above does not
constitute incorporation of any of the information thereon into
this press release.
CONDENSED
CONSOLIDATED BALANCE SHEET SUMMARY (UNAUDITED) |
|
(U.S.
Dollars) |
|
|
|
|
|
|
|
|
|
September
30, 2016 |
|
December
31, 2015 |
|
ASSETS |
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
Cash and cash equivalents |
|
$ |
10,557,870 |
|
$ |
10,698,405 |
|
Trade receivables |
|
|
17,226,850 |
|
|
17,401,479 |
|
Unbilled receivables |
|
|
11,709,032 |
|
|
12,132,484 |
|
Other accounts receivable and prepaid |
|
|
2,403,509 |
|
|
1,007,358 |
|
Inventories |
|
|
10,569,742 |
|
|
9,607,836 |
|
Discontinued Operations |
|
|
40,000 |
|
|
– |
|
TOTAL CURRENT ASSETS |
|
|
52,507,003 |
|
|
50,847,562 |
|
LONG TERM ASSETS: |
|
|
|
|
|
|
|
Property and equipment, net |
|
|
6,010,908 |
|
|
6,385,238 |
|
Other long term assets |
|
|
4,812,096 |
|
|
5,394,158 |
|
Intangible assets, net |
|
|
7,197,744 |
|
|
9,334,730 |
|
Goodwill |
|
|
45,627,221 |
|
|
45,463,027 |
|
Discontinued operations |
|
|
307,957 |
|
|
68,301 |
|
TOTAL LONG TERM ASSETS |
|
|
63,955,926 |
|
|
66,645,454 |
|
TOTAL ASSETS |
|
$ |
116,462,929 |
|
$ |
117,493,016 |
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS’ EQUITY |
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
Trade payables |
|
$ |
4,693,744 |
|
$ |
5,914,042 |
|
Other accounts payable and accrued expenses |
|
|
4,808,672 |
|
|
5,560,040 |
|
Current portion of long term debt |
|
|
1,664,831 |
|
|
4,362,438 |
|
Short term bank credit |
|
|
7,409,208 |
|
|
4,060,000 |
|
Deferred revenues |
|
|
5,808,304 |
|
|
6,879,815 |
|
Discontinued operations |
|
|
524,052 |
|
|
– |
|
TOTAL CURRENT LIABILITIES |
|
|
24,908,811 |
|
|
26,776,335 |
|
LONG TERM LIABILITIES: |
|
|
|
|
|
|
Accrued Israeli statutory/contractual severance
pay |
|
|
7,215,612 |
|
|
7,497,685 |
|
Long term portion of debt |
|
|
9,164,244 |
|
|
11,856,522 |
|
Other long-term liabilities |
|
|
7,733,403 |
|
|
7,295,808 |
|
Discontinued operations |
|
|
55,678 |
|
|
19,295 |
|
TOTAL LONG-TERM LIABILITIES |
|
|
24,168,937 |
|
|
26,669,310 |
|
TOTAL LIABILITIES |
|
|
49,077,748 |
|
|
53,445,645 |
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
TOTAL STOCKHOLDERS' EQUITY
(NET) |
|
|
67,385,181 |
|
|
64,047,371 |
|
TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY |
|
$ |
116,462,929 |
|
$ |
117,493,016 |
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE
INCOME (Unaudited) |
(U.S. Dollars, except share data) |
|
|
Nine months ended September 30, |
|
Three months ended September 30, |
|
|
2016 |
|
|
|
2015 |
|
|
|
2016 |
|
|
|
2015 |
|
Revenues |
$ |
71,486,478 |
|
|
$ |
69,160,381 |
|
|
$ |
24,300,120 |
|
|
$ |
23,289,448 |
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
48,933,171 |
|
|
|
49,005,379 |
|
|
|
16,436,276 |
|
|
|
16,254,419 |
|
Research and
development expenses |
|
2,367,964 |
|
|
|
2,697,121 |
|
|
|
752,847 |
|
|
|
680,414 |
|
Selling and marketing
expenses |
|
4,913,076 |
|
|
|
3,810,662 |
|
|
|
1,458,622 |
|
|
|
1,187,872 |
|
General and
administrative expenses |
|
11,149,640 |
|
|
|
12,270,493 |
|
|
|
3,122,853 |
|
|
|
4,089,442 |
|
Amortization of
intangible assets |
|
2,164,937 |
|
|
|
2,286,384 |
|
|
|
698,297 |
|
|
|
720,117 |
|
Total operating costs
and expenses |
|
69,528,788 |
|
|
|
70,070,039 |
|
|
|
22,468,895 |
|
|
|
22,932,264 |
|
|
|
|
|
|
|
|
|
Operating income
(loss) |
|
1,957,690 |
|
|
|
(909,658 |
) |
|
|
1,831,225 |
|
|
|
357,184 |
|
|
|
|
|
|
|
|
|
Other income
(loss) |
|
49,913 |
|
|
|
(55,678 |
) |
|
|
3,481 |
|
|
|
(105,709 |
) |
Financial expenses,
net |
|
(769,328 |
) |
|
|
(887,771 |
) |
|
|
(227,474 |
) |
|
|
(316,766 |
) |
Total other income /
(expense) |
|
(719,415 |
) |
|
|
(943,449 |
) |
|
|
(223,993 |
) |
|
|
(422,475 |
) |
Income / (loss) from
continuing operations before income tax expense |
|
1,238,275 |
|
|
|
(1,853,107 |
) |
|
|
1,607,232 |
|
|
|
(65,291 |
) |
|
|
|
|
|
|
|
|
Income tax expense |
|
684,272 |
|
|
|
899,629 |
|
|
|
101,992 |
|
|
|
289,905 |
|
Income (loss) from
continuing operations |
|
554,003 |
|
|
|
(2,752,736 |
) |
|
|
1,505,240 |
|
|
|
(355,196 |
) |
Loss from discontinued
operations, net of income tax |
|
(1,361,787 |
) |
|
|
(590,882 |
) |
|
|
(869,302 |
) |
|
|
(262,775 |
) |
Net income (loss) |
|
(807,784 |
) |
|
|
(3,343,618 |
) |
|
|
635,938 |
|
|
|
(617,971 |
) |
Other comprehensive
income, net of income tax |
|
|
|
|
|
|
|
Foreign currency
translation adjustment |
|
406,892 |
|
|
|
(106,019 |
) |
|
|
344,837 |
|
|
|
(489,365 |
) |
Comprehensive
income |
$ |
(400,892 |
) |
|
$ |
(3,449,637 |
) |
|
$ |
980,775 |
|
|
$ |
(1,107,336 |
) |
|
|
|
|
|
|
|
|
Basic net income per
share – continuing operations |
$ |
0.02 |
|
|
$ |
(0.12 |
) |
|
$ |
0.06 |
|
|
$ |
(0.02 |
) |
Basic net income/loss
per share – discontinued operations |
$ |
(0.05 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.01 |
) |
Basic net income per
share |
$ |
(0.03 |
) |
|
$ |
(0.14 |
) |
|
$ |
0.02 |
|
|
$ |
(0.03 |
) |
|
|
|
|
|
|
|
|
Diluted net income per
share – continuing operations |
$ |
0.02 |
|
|
$ |
(0.12 |
) |
|
$ |
0.06 |
|
|
$ |
(0.02 |
) |
Diluted net income/loss
per share – discontinued operations |
$ |
(0.05 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.01 |
) |
Diluted net income per
share |
$ |
(0.03 |
) |
|
$ |
(0.14 |
) |
|
$ |
0.02 |
|
|
$ |
(0.03 |
) |
Weighted average number
of shares used in computing basic net income/loss per share |
|
26,125,819 |
|
|
|
23,452,773 |
|
|
|
26,215,049 |
|
|
|
23,684,904 |
|
Weighted average number
of shares used in computing diluted net income/loss per share |
|
26,125,819 |
|
|
|
23,452,773 |
|
|
|
26,215,049 |
|
|
|
23,684,904 |
|
Reconciliation of Non-GAAP Financial
Measure – Continuing Operations
To supplement Arotech’s consolidated financial
statements presented in accordance with U.S. GAAP, Arotech uses a
non-GAAP measure, Earnings Before Interest, Taxes, Depreciation and
Amortization (EBITDA). This non-GAAP measure is provided to enhance
overall understanding of Arotech’s current financial performance
and its progress towards GAAP profitability. Reconciliation of
EBITDA to the nearest GAAP measure follows:
|
Nine months ended September 30, |
|
Three months ended September 30, |
|
|
2016 |
|
|
|
2015 |
|
|
|
2016 |
|
|
|
2015 |
|
Net income continuing
operations (GAAP measure) |
$ |
554,003 |
|
|
$ |
(2,752,736 |
) |
|
$ |
1,505,240 |
|
|
$ |
(355,196 |
) |
Add back: |
|
|
|
|
|
|
|
Financial expense –
including interest |
|
719,415 |
|
|
|
943,449 |
|
|
|
223,993 |
|
|
|
422,475 |
|
Income tax expenses |
|
684,272 |
|
|
|
899,629 |
|
|
|
101,992 |
|
|
|
289,905 |
|
Depreciation and
amortization expense |
|
3,487,532 |
|
|
|
3,662,420 |
|
|
|
1,152,865 |
|
|
|
1,179,937 |
|
Other adjustments* |
|
785,738 |
|
|
|
1,601,190 |
|
|
|
137,252 |
|
|
|
258,759 |
|
Building sale |
|
– |
|
|
|
(895,000 |
) |
|
|
– |
|
|
|
– |
|
Total adjusted EBITDA from
continuing operations |
$ |
6,230,960 |
|
|
$ |
3,458,952 |
|
|
$ |
3,121,342 |
|
|
$ |
1,795,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Includes stock compensation expense, one-time transaction
expenses and other non-cash expenses. |
Calculation
of Adjusted Earnings Per Share |
(U.S. $ in
thousands, except per share data) |
|
|
|
Nine months ended September
30, |
|
Three Months ended September 30, |
|
|
|
2016 |
|
|
|
2015 |
|
|
|
2016 |
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
Revenue (GAAP
measure) |
|
$ |
71,486 |
|
|
$ |
69,160 |
|
|
$ |
24,300 |
|
|
$ |
23,289 |
|
Net income (loss) from
continuing operations (GAAP measure) |
|
$ |
554 |
|
|
$ |
(2,753 |
) |
|
$ |
1,505 |
|
|
$ |
(355 |
) |
Adjustments: |
|
|
|
|
|
|
|
|
Amortization |
|
|
2,165 |
|
|
|
2,286 |
|
|
|
698 |
|
|
|
720 |
|
Stock compensation |
|
|
786 |
|
|
|
476 |
|
|
|
137 |
|
|
|
141 |
|
Non-cash taxes |
|
|
608 |
|
|
|
687 |
|
|
|
229 |
|
|
|
387 |
|
EFB transition/UEC
acquisition costs |
|
|
– |
|
|
|
1,126 |
|
|
|
– |
|
|
|
118 |
|
Building sale gain |
|
|
– |
|
|
|
(895 |
) |
|
|
– |
|
|
|
– |
|
Net adjustments |
|
$ |
3,559 |
|
|
$ |
3,680 |
|
|
$ |
1,064 |
|
|
$ |
1,366 |
|
Adjusted net income |
|
$ |
4,113 |
|
|
$ |
927 |
|
|
$ |
2,569 |
|
|
$ |
1,011 |
|
Number of shares |
|
|
26,126 |
|
|
|
23,453 |
|
|
|
26,215 |
|
|
|
23,685 |
|
Adjusted EPS from
continuing operations |
|
$ |
0.16 |
|
|
$ |
0.04 |
|
|
$ |
0.10 |
|
|
$ |
0.04 |
|
Arotech (NASDAQ:ARTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arotech (NASDAQ:ARTX)
Historical Stock Chart
From Apr 2023 to Apr 2024